Physician profile
Debra E Evola
NPI 1457492761
$929.71
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $432 · 2022: $425 · 2024: $72.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $72.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $72.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $228.16 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $202.00 | 2022 | |
| Boston Scientific Corporation | $167.22 | 2021-2022 | |
| Eisai INC. | $125.00 | 2021 | |
| Abbvie INC. | $71.39 | 2021-2024 | |
| Lilly USA, LLC | $49.64 | 2021-2022 | |
| Sk Life Science, INC. | $27.76 | 2021 | |
| Merz Pharmaceuticals, LLC | $22.70 | 2024 | Xeomin |
| Biohaven Pharmaceutical Holding Company Ltd. | $20.40 | 2022 | |
| Horizon Therapeutics Plc | $15.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Evola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.